FN2 Earnings Intelligence

Bio-Techne Corporation analyst ratings

Bio-Techne Corporation (TECH) analyst consensus, price targets, and firm-level rating history from FN2 Research.

Analyst Consensus ?

ConsensusBuy24 ratings
Bullish1250.0%
Neutral1250.0%
Bearish00.0%

1 unmapped firm rating excluded from the percentages.

Analyst 52W Price Targets

$72.71Current
$49Low
$75.3Average
$106.25High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 29, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Wells Fargo Equal Weight OverweightDowngradeAug 13, 2026
RBC Capital Sector Perform OutperformDowngradeJul 9, 2026
TD Cowen Hold BuyDowngradeJun 30, 2026
Benchmark Hold BuyDowngradeJun 30, 2026
Citigroup Neutral BuyDowngradeJun 29, 2026
Show 20 more rating actions

Named analyst price targets

Upside is calculated against the persisted current price $72.71. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Wells FargoAnalyst unavailable$73$72.22 +0.4%Aug 13, 2026
StephensSteven Etoch$73$71.16 +0.4%Jun 26, 2026
Robert W. BairdCatherine Ramsey Schulte$73$70.7 +0.4%Jun 26, 2026
Deutsche BankJustin Bowers$73$70.7 +0.4%Jun 26, 2026
Leerink PartnersMarket Perform$73$70.54 +0.4%Jun 25, 2026
See 24 more

Track every rating change on TECH the moment it posts. Free to start.

Start free

Get the TECH recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.